AbCellera Biologics Inc.

An AI-powered platform that discovers and develops antibody therapeutics for pharma partners.

ABCL | NDAQ

Overview

Corporate Details

ISIN(s):: N/A
LEI:
Country:: United States of America
Address:: 150 W 4TH AVENUE, VANCOUVER
Website:: https://www.abcellera.com/
Sector:: Mining and quarrying
Industry:: Mining of non-ferrous metal ores

Description

AbCellera Biologics Inc. is a clinical-stage biotechnology company that discovers and develops antibody-based therapeutics. The company operates a proprietary, AI-powered drug discovery platform that integrates advanced technologies in biology, computation, and engineering. This full-stack platform is designed to search, decode, and analyze natural immune systems at high speed and scale to find novel antibodies for therapeutic development. AbCellera partners with pharmaceutical and biotech companies to advance a pipeline of first-in-class and best-in-class antibody programs across various therapeutic areas, including cancer and endocrinology. The platform supports the development of complex modalities, such as bispecifics and antibody-drug conjugates, for conditions with high unmet medical need.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.

Quick Filters:

Filters

Filing Type

Language

Start date

End date

Clear

Bulk Actions:

	Date	Filing	Language	Size	Actions
No filings match the current criteria.

Automate Your Workflow. Get a real-time feed of all AbCellera Biologics Inc. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for AbCellera Biologics Inc.

This data is available as part of our premium data solutions. Contact our team for access.

Request This Data

Need More History? Access decades of standardized financials for AbCellera Biologics Inc. via our API.

Get Historical Data →

Insider Transactions

Date	Insider Name	Position	Type	Shares	Value
No insider transactions recorded for this company.

Peer Companies

Company	Country	Ticker
1NKEMIA A tech group providing R&D, services, training, and investment for life sciences industries.	Spain	IKM
3billion Inc. AI-powered genome sequencing and reanalysis to diagnose rare diseases globally.	South Korea	394800
4D Molecular Therapeutics, Inc. Developing targeted AAV genetic medicines for large market eye, lung, and heart diseases.	United States of America	FDMT
AbClon Inc. Develops antibody therapeutics and CAR-T for oncology and provides CRO services.	South Korea	174900
ABION Inc. Clinical-stage biopharma developing therapeutics for oncology & viral infectious diseases.	South Korea	203400
Abivax S.A. Biotech developing oral drugs for chronic inflammatory diseases like colitis and Crohn's.	United States of America	ABVX
ABL Bio Inc. Develops bispecific antibody therapies for oncology and neurodegenerative diseases.	South Korea	298380
Absci Corp A generative AI drug creation platform for designing and optimizing biologic therapeutics.	United States of America	ABSI
ABVC BIOPHARMA, INC. Develops plant-based drugs and medical devices for CNS, oncology, and ophthalmic disorders.	United States of America	ABVC
Acrivon Therapeutics, Inc. Develops precision cancer therapies by matching patients to drugs using its proteomics platform.	United States of America	ACRV